Chief Pathologist @Histowiz #Telepathology #DigitalPathology #AI @NCI @msk @CAP @mssm #mom #pathpower20 @PathOutlines @ASHScientificCommittee
New York, NY
Joined March 2012
- Tweets45.5K
- Following3.8K
- Followers6.6K
- Likes61.1K
Julie Feldstein,MD retweeted
October is Breast Cancer Awareness Month
#BreastCancer is the most common cancer among women globally and represents approximately a quarter of all cancers that occur in women every year.
With 1 in 6 cancer deaths in women worldwide, breast cancer is also the leading cause of cancer deaths among women globally.
Breast cancer is highly curable if detected in its early stages and adequate treatment is provided bit.ly/4o0GzFS
Julie Feldstein,MD retweeted
There is a 60% survival difference between woman with #BreastCancer living in high-income countries vs those living in low-and-middle income countries.
Global Breast Cancer Initiative is raising awareness, sharing knowledge, and advocating for stronger health systems to improve survival for all bit.ly/4s8xBcU
Julie Feldstein,MD retweeted
Just published @ScienceMagazine
Higher medical accuracy at lower cost
A 3-agent AI for sequential diagnosis nearly doubled accuracy compared with physicians for >300 @NEJM CPC cases and >300 ER cases AND substantially lowered cost, also exceeded performance of many AI models, physicians plus AI @HarshaNori
@erichorvitz @Dominic1King @mustafasuleyman
Julie Feldstein,MD retweeted
"The longevity industry is a goldrush without gold."
and other strong words about 2 delusions @TheLancet
thelancet.com/journals/lance…
Julie Feldstein,MD retweeted
What is "medical superintelligence" and why are we so far away from the concept?
open-access
bmjdigitalhealth.bmj.com/con…
Julie Feldstein,MD retweeted
Delighted to welcome Professor Pembe Oltulu as a new Social Media Editor at the Journal of Clinical Pathology!
Pembe joins Archana Bhat and our social media team to share JCP research, encourage conversation, and connect our global pathology community.
Welcome to the team, Pembe!
#Pathology #JClinPath
ALT Portrait of Professor Pembe Oltulu wearing glasses, a patterned headscarf and a white coat.
Julie Feldstein,MD retweeted
In 100% agreement
Exercise should be a prescribed
New @JACCJournals @ACCinTouch scientific statement
jacc.org/doi/10.1016/j.jacc.…
Julie Feldstein,MD retweeted
Spotlighting the macrophage cells in our blood and tissue, their role in diseases, and targeted interventions
cell.com/immunity/fulltext/S… @ImmunityCP
Julie Feldstein,MD retweeted
On the uncertainties of AI in health care including implementation and need for post-deployment assessment
Over 800 public healthcare systems have deployed China's DeepSeek model
@NatureMedicine
nature.com/articles/s41591-0…
Julie Feldstein,MD retweeted
Kīlauea Eruption Update — Episode 55 of lava fountaining!
After nearly two months since episode 54 of lava fountaining (Aug. 25, 2026), episode 55 of Kīlauea summit lava fountaining began at 3:19 a.m. HST this morning, October 17, and is ongoing.
This is the 55th lava fountaining episode in the Kīlauea summit caldera eruption in Hawai‘i Volcanoes National Park that began on December 23, 2024. It occurs following weeks of intermittent spatter, low-dome fountains, and lava flows from the eruptive vent complex. The lava fountain from the north vent reached an estimated 700 feet high above the vent around 5 a.m. Hawaii Standard Time.
The eruptive plume is reaching an estimated 25,000 feet above sea level. According to the National Weather Service, winds are blowing from the north-northeast direction, which suggests that volcanic gas emissions and volcanic material may be distributed to the south-southwest.
Fountaining episodes typically last 12 hours or less, but ash can remain in the air for longer depending on wind and weather conditions.
Please stay aware of hazards and rely on official updates from USGS, National Weather Service, and Hawai’i Volcanoes National Park.
🎥 Video of episode 55 on October 17, 2026.
#Kilauea #Eruption #Lava
Julie Feldstein,MD retweeted
Could we please congratulate @MeredithKHerman ✨️
@JMGardnerMD @smlungpathguy @GeronimoJrLapac @pepeheffernan @KMirza @Histopatolomon @VijayPatho @HermelinMD @DrGeeONE @Path_Matt @feldstej @evemariecrane @Sinchita_Roy @Sara_Jiang @mreyesm
@antonietagalvao @DianaEstherossi
📣 Each month, our team of screening judges selects a standout tweet from the trainee category for the #PathTweetAward.
📅 For September 2026, the winner is:🏆 @MeredithKHerman
Congratulations to our September 2026 #PathTweetAward winner! @MeredithKHerman
@PathTweetAward
Julie Feldstein,MD retweeted
@JMGardnerMD @smlungpathguy @GeronimoJrLapac @pepeheffernan @KMirza @Histopatolomon @VijayPatho @HermelinMD @Vik_deshpandeMD @DrGeeONE @Path_Matt @feldstej @evemariecrane @Sinchita_Roy @Sara_Jiang @mreyesm
@antonietagalvao @mlage @DianaEstherossi @NayarRitu @eva_wojcik @barkanga
A must-read for pathologists and cancer researchers!
“Claudin 18.2 in Cancer Research and Treatment: A Pathologist's Perspective” — a Systematic Review by Gurzhikhan Murtazaalieva, Angela Baldwin, Matteo Fassan and Vikram Deshpande, published in the Journal of Clinical Pathology.
What makes it particularly relevant for us as pathologists is the growing importance of morphology, immunohistochemistry and biomarker interpretation in guiding targeted therapies.
Link to the article bit.ly/4gzmLao
Julie Feldstein,MD retweeted
Congratulations to September's #PathArt winner, Ali Khrayzat, MD, as voted by the CAP’s Digital Content Committee. Check out Dr. Khrayzat's piece, title "Cyst from Jupiter.”
Make sure you pick up a copy of the #PathArt calendar at #CAP26!
CAP members, submit your PathArt for next month’s contest here: lnkd.in/eV5GtSvk
Julie Feldstein,MD retweeted
Voided urine containing what type of crystals? Answer: buff.ly/46CW5Pe #PathArt #CytoPath #PathTwitter buff.ly/3YH0tKV
Julie Feldstein,MD retweeted
My recent commission piece:
Dog bone marrow with marked myeloid hyperplasia due to the parasite Hepatozoon americanum 🎨🔬
Read about the case & #PathArt inspiration
allscience.substack.com/p/ba…
#WhiteCoatArtistry #PathX #VetPath
